Growing community of inventors

Paris, France

Fanny Mochel

Average Co-Inventor Count = 2.59

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 102

Fanny MochelRaphael Schiffmann (4 patents)Fanny MochelSabrina Forni (2 patents)Fanny MochelAlexandra Durr (2 patents)Fanny MochelLawrence Sweetman (2 patents)Fanny MochelGiovanni Stevanin (1 patent)Fanny MochelMaxime Boutry (1 patent)Fanny MochelFrédéric Darios (1 patent)Fanny MochelJulien Branchu (1 patent)Fanny MochelFanny Mochel (7 patents)Raphael SchiffmannRaphael Schiffmann (6 patents)Sabrina ForniSabrina Forni (2 patents)Alexandra DurrAlexandra Durr (2 patents)Lawrence SweetmanLawrence Sweetman (2 patents)Giovanni StevaninGiovanni Stevanin (5 patents)Maxime BoutryMaxime Boutry (1 patent)Frédéric DariosFrédéric Darios (1 patent)Julien BranchuJulien Branchu (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Institut National De La Sante Et De La Recherche Medicale (3 from 1,743 patents)

2. Baylor Research Institute (3 from 93 patents)

3. National Institute of Health and Medical Research (2 from 2 patents)

4. Other (1 from 832,718 patents)

5. Centre National De La Recherche Scientifique (1 from 5,072 patents)

6. Sorbonne Université (1 from 236 patents)

7. Icm-institut Du Cerveau Et De La Moelle Epiniere (1 from 9 patents)

8. Aphp (Assistance Publique-Hôpitaux De Paris) (1 from 9 patents)

9. Ecole Pratique Des Hautes Etudes (1 from 5 patents)

10. Baylor Research Institute at Dallas (0 patent)


7 patents:

1. 11065238 - Inhibitors of gangliosides metabolism for the treatment of motor neuron diseases

2. 10220014 - Anaplerotic therapy of huntington disease and other polyglutamine diseases

3. 10111848 - Triheptanoin for the treatment of glucose transport 1 deficiency

4. 9750732 - Urinary triaosylceramide (Gb3) as a marker of cardiac disease

5. 9717705 - Anaplerotic therapy of huntington disease and other polyglutamine diseases

6. 9468229 - Triheptanoin for the treatment of glucose transport 1 deficiency

7. 9066939 - Urinary triaosylceramide (GB3) as a marker of cardiac disease

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/11/2025
Loading…